BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 34365635)

  • 21. Immunotherapy for advanced or metastatic urothelial carcinoma.
    Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Kim J; MacDonald R; Reddy B; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012615. PubMed ID: 29161773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testosterone replacement in men with sexual dysfunction.
    Lee H; Hwang EC; Oh CK; Lee S; Yu HS; Lim JS; Kim HW; Walsh T; Kim MH; Jung JH; Dahm P
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013071. PubMed ID: 38224135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi.
    Ordonez M; Hwang EC; Borofsky M; Bakker CJ; Gandhi S; Dahm P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012703. PubMed ID: 30726554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
    Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticholinergics combined with alpha-blockers for treating lower urinary tract symptoms related to benign prostatic obstruction.
    Pang R; Zhou XY; Wang X; Wang B; Yin XL; Bo H; Jung JH
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD012336. PubMed ID: 33567116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective serotonin re-uptake inhibitors for premature ejaculation in adult men.
    Sathianathen NJ; Hwang EC; Mian R; Bodie JA; Soubra A; Lyon JA; Sultan S; Dahm P
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012799. PubMed ID: 33745183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Philippou YA; Kuntz GM; Konety BR; Gupta S; Lamb AD; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012816. PubMed ID: 30320443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; Reddy B; McCutcheon KA; Borofsky M; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD012832. PubMed ID: 31128077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
    Hwang EC; Gandhi S; Jung JH; Imamura M; Kim MH; Pang R; Dahm P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007360. PubMed ID: 30306544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posterior musculofascial reconstruction after radical prostatectomy: a systematic review of the literature.
    Rocco B; Cozzi G; Spinelli MG; Coelho RF; Patel VR; Tewari A; Wiklund P; Graefen M; Mottrie A; Gaboardi F; Gill IS; Montorsi F; Artibani W; Rocco F
    Eur Urol; 2012 Nov; 62(5):779-90. PubMed ID: 22664219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degarelix for treating advanced hormone-sensitive prostate cancer.
    Zengerling F; Jakob JJ; Schmidt S; Meerpohl JJ; Blümle A; Schmucker C; Mayer B; Kunath F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD012548. PubMed ID: 34350976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retzius Sparing Radical Prostatectomy Versus Robot-assisted Radical Prostatectomy: Which Technique Is More Beneficial for Prostate Cancer Patients (MASTER Study)? A Systematic Review and Meta-analysis.
    Barakat B; Othman H; Gauger U; Wolff I; Hadaschik B; Rehme C
    Eur Urol Focus; 2022 Jul; 8(4):1060-1071. PubMed ID: 34429272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cryotherapy for localised or locally advanced prostate cancer.
    Jung JH; Risk MC; Goldfarb R; Reddy B; Coles B; Dahm P
    Cochrane Database Syst Rev; 2018 May; 5(5):CD005010. PubMed ID: 29845595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic review on urinary continence rates after robot-assisted laparoscopic radical prostatectomy.
    Geraghty K; Keane K; Davis N
    Ir J Med Sci; 2024 Jun; 193(3):1603-1612. PubMed ID: 38200383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NeuroSAFE robot-assisted laparoscopic prostatectomy versus standard robot-assisted laparoscopic prostatectomy for men with localised prostate cancer (NeuroSAFE PROOF): protocol for a randomised controlled feasibility study.
    Dinneen E; Haider A; Allen C; Freeman A; Briggs T; Nathan S; Brew-Graves C; Grierson J; Williams NR; Persad R; Oakley N; Adshead JM; Huland H; Haese A; Shaw G
    BMJ Open; 2019 Jun; 9(6):e028132. PubMed ID: 31189680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.